Clinical Laboratories

The Future of Precision Medicine Starts at the Moment of Diagnosis OCTOBER 28, 2025 | 11:30AM ET | VIRTUAL EVENT Join Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision...

VISTA, California, September 30, 2025 – Leica Biosystems is proud to announce the launch of CytoVision DX, a next-generation image capture, analysis, and case management system purpose-built for clinical cytogenetics laboratories. Now CE-IVDR...

Proscia: Delivering a menu of H&E, IHC, and special stains on the Concentriq platform PHILADELPHIA and LOS ANGELES – September 24, 2025 – Proscia®, a pathology AI company, is introducing virtual staining in...

Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...

The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...

AiosynQC and IVDR-certified Aiosyn Mitosis Breast are now available through Pathomation’s AI Marketplace, building on their AWAKE project collaboration to transform kidney diagnostics with AI. Antwerp, Belgium, and Nijmegen, Netherlands...